NovoCure
NVCR
NVCR
303 hedge funds and large institutions have $6.2B invested in NovoCure in 2022 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 96 increasing their positions, 90 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
303
Holders Change
+2
Holders Change %
+0.66%
% of All Funds
4.89%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
49
Increased
96
Reduced
90
Closed
39
Calls
$137M
Puts
$196M
Net Calls
-$59.1M
Net Calls Change
-$31.2M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$96M |
| 2 |
HIC
Hartline Investment Corp
Winnetka,
Illinois
|
+$22.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.8M |
| 4 |
BlackRock
New York
|
+$16.6M |
| 5 |
Aviva
London,
United Kingdom
|
+$8.87M |
Top Sellers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$98.3M |
| 2 |
Morgan Stanley
New York
|
-$32.4M |
| 3 |
State Street
Boston,
Massachusetts
|
-$28.4M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.9M |
| 5 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$11.9M |
